These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31290553)

  • 21. High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.
    Young-Xu Y; Thornton Snider J; Mahmud SM; Russo EM; Van Aalst R; Thommes EW; Lee JK; Chit A
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza Season.
    Imran M; Ortiz JR; McLean HQ; Fisher L; O'Brien D; Bonafede M; Mansi JA; Boikos C
    Pediatr Infect Dis J; 2022 Sep; 41(9):769-774. PubMed ID: 35797705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018.
    Boikos C; Sylvester GC; Sampalis JS; Mansi JA
    Clin Infect Dis; 2020 Dec; 71(10):e665-e671. PubMed ID: 32253431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design.
    Zimmerman RK; Dauer K; Clarke L; Nowalk MP; Raviotta JM; Balasubramani GK
    Hum Vaccin Immunother; 2023 Dec; 19(1):2177461. PubMed ID: 36809982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    Klein NP; Fireman B; Goddard K; Zerbo O; Asher J; Zhou J; King J; Lewis N
    PLoS One; 2020; 15(2):e0229279. PubMed ID: 32101582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017.
    Fabiani M; Volpe E; Faraone M; Bella A; Pezzotti P; Chini F
    Expert Rev Vaccines; 2020 May; 19(5):479-489. PubMed ID: 32237925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
    Lewis NM; Chung JR; Uyeki TM; Grohskopf L; Ferdinands JM; Patel MM
    Clin Infect Dis; 2022 Aug; 75(1):170-175. PubMed ID: 34875035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type.
    Ferdinands JM; Patel M
    Vaccine; 2022 Apr; 40(19):2797-2801. PubMed ID: 35331567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly.
    Lapi F; Marconi E; Simonetti M; Baldo V; Rossi A; Sessa A; Cricelli C
    Expert Rev Vaccines; 2019 Jun; 18(6):663-670. PubMed ID: 31155968
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Cho BH; Weinbaum C; Tsai Y; Koppaka R
    Ann Intern Med; 2022 Jan; 175(1):1-10. PubMed ID: 34781717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.
    Gravenstein S; Dahal R; Gozalo PL; Davidson HE; Han LF; Taljaard M; Mor V
    Clin Trials; 2016 Jun; 13(3):264-74. PubMed ID: 26908539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Adults During the 2019-2020 Influenza Season in the United States.
    Imran M; Ortiz JR; McLean HQ; Fisher L; O'Brien D; Bonafede M; Mansi JA; Boikos C
    Open Forum Infect Dis; 2022 Oct; 9(10):ofac532. PubMed ID: 36320195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
    Stuart B; Davidoff A; Lloyd J; Shaffer T; Shoemaker JS; Kemner J
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):201-14. PubMed ID: 20624610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.
    Szilagyi PG; Fairbrother G; Griffin MR; Hornung RW; Donauer S; Morrow A; Altaye M; Zhu Y; Ambrose S; Edwards KM; Poehling KA; Lofthus G; Holloway M; Finelli L; Iwane M; Staat MA;
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):943-51. PubMed ID: 18838647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season.
    Pelton SI; Divino V; Shah D; Mould-Quevedo J; DeKoven M; Krishnarajah G; Postma MJ
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32784684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose Versus Standard-dose Vaccines.
    Butler AM; Layton JB; Krueger WS; Kshirsagar AV; McGrath LJ
    Med Care; 2019 Jan; 57(1):73-78. PubMed ID: 30422840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.